Total medical devices industry venture financing deals worth $1.3bn were announced in the US in July 2021, led by $260m venture financing of Imperative Care , according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 25.9% over the previous month of $1.74bn and a rise of 13.2% when compared with the last 12-month average of $1.14bn.
The US held a 52.23% share of the global medical devices industry venture financing deal value that totalled $2.47bn in July 2021.
In terms of venture financing deal activity, the US recorded 37 deals during July 2021, marking a decrease of 43.94% over the previous month and a drop of 41.27% over the 12-month average.
US medical devices industry venture financing deals in July 2021: Top deals
The top five medical devices industry venture financing deals accounted for 57.4% of the overall value during July 2021.
The combined value of the top five medical devices venture financing deals stood at $740m, against the overall value of $1.3bn recorded for the month.
The top five medical devices industry venture financing deals of July 2021 tracked by GlobalData were:
1) Imperative Care $260m venture financing deal with Ally Bridge Group,AMED Ventures GP,Ascension Health Ventures,Bain Capital Life Sciences,D1 Capital Partners,Delos Capital,HealthCor Management,Innovatus Capital Partners and Rock Springs Capital Management
3) TMRW Life Sciences $105m venture financing deal with 5AM Venture Management,Anne Wojcicki,Casdin Capital,GV Management Co,Life Science Innovations Fund,Peter Thiel,Signature Bank,Susan Wojcicki and Transformation Capital
5) Woebot Health $90m venture financing deal with AI Fund,Alumni Ventures Group,BlackRock Private Equity Partners,Gaingels,Jazz Venture Partners,Kicker Ventures,Mirae Asset Capital,New Enterprise Associates,Owl Ventures and Temasek Holdings (Private)
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.